About one in nine American adults, or 11.4%, took prescription medication for depression in 2023. That’s tens of millions of people, and the number has climbed steadily for decades. The reasons aren’t simple: it’s not just that more people are depressed, and it’s not just that doctors prescribe too freely. The real answer involves changes in how we talk about mental health, how medicine is practiced, how long people stay on these medications, and what’s happening in modern life that affects mental health in the first place.
Who Is Taking Antidepressants
Women are roughly twice as likely as men to be on antidepressants: 15.3% of women compared to 7.4% of men. That gap reflects both biological differences in depression risk and the fact that women are more likely to seek medical help for emotional symptoms. Age plays a smaller role than you might expect. Adults 18 to 44 use antidepressants at a rate of 10.7%, while those 45 to 64 come in at 12.1% and those 65 to 74 at 12.4%. The numbers stay remarkably consistent across the adult lifespan.
The U.S. isn’t alone. Countries like Iceland, Canada, Portugal, the United Kingdom, and Australia all have antidepressant consumption rates above the international average, and most saw steep increases between 2010 and 2020. Iceland consistently leads the world in antidepressant use per capita. This is a pattern across wealthy nations, not a uniquely American phenomenon.
Less Stigma, More Diagnoses
One of the biggest drivers is straightforward: people are more willing to talk about depression than they were 20 or 30 years ago, and doctors are more willing to screen for it. The reduction in stigma surrounding mental illness has made it easier for someone to walk into a doctor’s office and say they’ve been struggling. Primary care physicians now routinely ask about mood during regular checkups, something that was far less common in previous decades. Improved access to mental health services and greater public awareness of depression symptoms have both contributed to more people receiving a diagnosis and, in turn, a prescription.
This doesn’t mean the increase is artificial. Many of these people were likely suffering in silence before. But it does mean that part of the rise reflects better detection of existing illness rather than a pure increase in how many people are depressed.
Primary Care Drives Most Prescriptions
The majority of antidepressant prescriptions come not from psychiatrists but from primary care doctors, your regular family physician or internist. In studies comparing the two, about 56% of primary care physicians were very likely to prescribe an antidepressant for mild depression. Psychiatrists were somewhat more likely to prescribe (70%), but they were also far more likely to combine medication with counseling: 61% of psychiatrists recommended both together, compared to just 30% of primary care doctors.
This matters because a 15-minute primary care appointment often doesn’t allow time to explore therapy options, lifestyle changes, or the full picture of what’s going on. The result is that medication becomes the default intervention, especially for mild to moderate cases where therapy alone might be equally effective. Only about half of primary care physicians actively promoted counseling for mild depression, while 86% of psychiatrists did so. The gap suggests that the setting where you first bring up your symptoms can shape what treatment you receive.
People Stay on Them for Years
A major reason the number of people on antidepressants keeps growing is that many who start never stop. Among long-term users in one large population study, the average duration of use was 5.5 years. Nearly half had been on antidepressants for five years or more, and about one in five had been taking them for over eight years.
Several forces keep people on these medications long after an initial depressive episode resolves. Doctors often continue prescriptions because they worry about relapse, sometimes without revisiting whether the medication is still necessary. There’s also a biological complication: withdrawal symptoms from antidepressants, including increased anxiety, dizziness, mood swings, insomnia, and nausea, occur in more than half of all users who try to stop. These withdrawal effects can look a lot like the depression coming back, which leads both patients and doctors to conclude the medication is still needed. Growing evidence suggests that depression relapse is seriously confused with withdrawal reactions, especially when doctors aren’t familiar with how antidepressant discontinuation actually works.
The result is a one-way door for many patients. Starting is easy, but stopping is complicated, and the medical system isn’t well set up to guide people through tapering safely.
Antidepressants Treat More Than Depression
Not everyone taking an antidepressant is taking it for depression. These medications are widely prescribed for anxiety disorders, chronic pain, insomnia, nerve pain, and other conditions. In older adults, chronic pain is actually the most common reason for starting a newer antidepressant. Certain types of antidepressants can dull pain signals or improve sleep at lower doses than would be used for depression itself.
This off-label use adds significantly to the total count. When surveys report that 11.4% of adults take medication “for depression,” they’re capturing the primary reported reason, but the broader universe of antidepressant prescriptions is even larger when you include these other uses.
Modern Life and Mental Health
There’s also real evidence that the conditions of modern life are generating more distress. Loneliness and social disconnection have become pervasive enough that the CDC now tracks them as public health concerns. Adults who report feeling lonely are about 2.4 times as likely to have a history of depression compared to those who don’t. They’re three times as likely to experience frequent mental distress and 3.6 times as likely to report significant stress.
These aren’t small effects. Loneliness, economic pressure, social media use, and the erosion of community ties all create the kind of chronic low-grade suffering that often lands in a doctor’s office as “I think I might be depressed.” And for many people, that visit ends with a prescription. The underlying social problems don’t have a pharmaceutical fix, but the symptoms they produce are treatable with medication, at least partially. This creates a cycle where structural problems in how people live get channeled into individual medical treatment.
Putting It All Together
The rise in antidepressant use isn’t explained by any single factor. It’s the combined effect of more people seeking help, more doctors screening for depression, primary care settings that favor medication over therapy, long treatment durations driven partly by withdrawal difficulties, widespread off-label prescribing, and genuine increases in the social conditions that cause depression and anxiety. Each of these forces pushes the number higher, and they reinforce each other. More awareness leads to more diagnoses, more diagnoses lead to more prescriptions, and more prescriptions lead to more long-term users who never come off the medication.
Whether this is a success story or a problem depends on which piece you focus on. For people with severe, recurrent depression, broader access to antidepressants has been lifesaving. For others with mild symptoms who might have benefited more from therapy or lifestyle changes, the ease of getting a prescription may have substituted for more effective approaches. And for the large group stuck on medications they no longer need but can’t easily quit, the system has created a problem it hasn’t yet learned to solve.